Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -73.64%-3.85M | -55.34%-851.19K | -67.76%-1.3M | -122.48%-1.28M | -30.93%-414.95K | -0.12%-2.22M | -55.10%-547.96K | 2.21%-775.44K | -6.50%-575.95K | 39.82%-316.92K |
| Net income from continuing operations | -24.00%-3.02M | 21.48%-623.18K | -86.63%-883.56K | -31.99%-890.13K | -26.14%-623.43K | -4.89%-2.44M | -288.78%-793.64K | 49.33%-473.42K | -23.00%-674.38K | 22.22%-494.26K |
| Operating gains losses | -151.73%-224 | ---153 | 125.41%46 | -151.75%-133 | -95.52%16 | 3,430.77%433 | --0 | -770.37%-181 | 213.41%257 | 390.24%357 |
| Depreciation and amortization | -17.47%78.46K | -17.50%19.98K | -17.49%19.98K | -17.47%19.8K | -17.42%18.7K | -17.93%95.06K | -17.95%24.22K | -17.95%24.22K | -17.93%23.99K | -17.88%22.64K |
| Asset impairment expenditure | --202.5K | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | -214.28%-6.46K | -66.65%808 | -250.00%-4.85K | --0 | ---2.42K | -46.15%5.65K | 200.00%2.42K | 299.75%3.23K | --0 | --0 |
| Remuneration paid in stock | 21.49%52.4K | 18.51%10.62K | 38.54%8.74K | 11.24%25.25K | 50.89%7.8K | -49.99%43.13K | -14.25%8.96K | -57.76%6.31K | -24.68%22.7K | -83.18%5.17K |
| Other non cashItems | -476.76%-921.56K | 86.99%-14K | -2,080.37%-419.22K | ---347.21K | ---141.13K | -33.48%-159.78K | -158.93%-107.57K | ---19.23K | ---- | ---- |
| Change In working capital | -199.26%-233.2K | -177.21%-245.27K | 29.03%-224.53K | -205.26%-88.93K | 118.22%325.53K | 1,395.87%234.93K | 318.84%317.64K | -281.52%-316.37K | 253.08%84.48K | 257.30%149.17K |
| -Change in receivables | 31.62%66.17K | 61.72%-34.72K | -109.80%-11.56K | 53.86%-40.37K | 38.33%152.81K | -89.99%50.27K | -222.39%-90.7K | 237.41%117.98K | -128.19%-87.48K | -45.69%110.47K |
| -Change in prepaid assets | -862.07%-306.21K | -276.11%-329.24K | 108.04%15.5K | -24.18%15.5K | -131.14%-7.96K | -43.31%40.18K | 1,798.62%186.95K | -2,269.23%-192.76K | -67.28%20.44K | 142.35%25.55K |
| -Change in payables and accrued expense | -95.26%6.84K | -46.39%118.7K | 5.43%-228.46K | -142.28%-64.06K | 1,273.91%180.67K | 125.93%144.47K | 206.31%221.39K | -196.15%-241.59K | 135.40%151.52K | 107.64%13.15K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -73.64%-3.85M | -55.34%-851.19K | -67.76%-1.3M | -122.48%-1.28M | -30.93%-414.95K | -0.12%-2.22M | -55.10%-547.96K | 2.21%-775.44K | -6.50%-575.95K | 39.82%-316.92K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -6,150.00%-2.5M | -2.5M | 0 | 0 | 0 | -60.00%-40K | 0 | 0 | 0 | -40K |
| Net PPE purchase and sale | --0 | --0 | --0 | --0 | --0 | -60.00%-40K | --0 | --0 | --0 | ---40K |
| Net investment purchase and sale | ---2.5M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -6,150.00%-2.5M | ---2.5M | --0 | --0 | --0 | -60.00%-40K | --0 | --0 | --0 | ---40K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 500.11%11.08M | 2,006.61%8.45M | 157.36%2.26M | 131.13%1.85M | 967.31%401.13K | 4.12%879.97K | ||||
| Net common stock issuance | 471.14%11.13M | 2,433.88%8.89M | 128.01%2.24M | ---- | ---- | 123.64%1.95M | --351K | 12.63%981.55K | ---- | ---- |
| Proceeds from stock option exercised by employees | --105.86K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | -52.46%-156.3K | -1,196.07%-549.48K | 126.21%26.62K | ---- | ---- | -41.20%-102.51K | 208.39%50.13K | ---101.58K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 500.11%11.08M | 2,006.61%8.45M | 157.36%2.26M | ---- | ---- | 131.13%1.85M | 967.31%401.13K | 4.12%879.97K | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -13.27%2.68M | -18.14%2.31M | -50.40%1.35M | -17.12%2.26M | -13.27%2.68M | -31.79%3.09M | -19.57%2.83M | -21.38%2.72M | -31.74%2.73M | -31.79%3.09M |
| Current changes in cash | 1,255.25%4.73M | 3,572.87%5.1M | 822.05%963.77K | -8,623.16%-914.8K | -16.26%-414.95K | 71.54%-409.7K | 65.41%-146.83K | 100.27%104.52K | 98.06%-10.49K | 32.23%-356.92K |
| Effect of exchange rate changes | 151.73%224 | --153 | -125.41%-46 | 151.75%133 | 95.52%-16 | -3,430.77%-433 | --0 | 770.37%181 | -213.41%-257 | -390.24%-357 |
| End cash Position | 176.63%7.41M | 176.63%7.41M | -18.14%2.31M | -50.40%1.35M | -17.12%2.26M | -13.27%2.68M | -13.27%2.68M | -19.57%2.83M | -21.38%2.72M | -31.74%2.73M |
| Free cash from | -70.56%-3.85M | -55.34%-851.19K | -67.76%-1.3M | -122.48%-1.28M | -16.26%-414.95K | -0.79%-2.26M | -44.85%-547.96K | 2.21%-775.44K | -6.50%-575.95K | 32.23%-356.92K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.